KNEES — Sales to customers (Note 9)
Products & Services · Sales to customers (Note 9)Johnson & Johnson KNEES — Sales to customers (Note 9) decreased by 3.3% to $753.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.0%, from $704.00M to $753.00M. Over 2 years (FY 2021 to FY 2024), KNEES — Sales to customers (Note 9) shows an upward trend with a 14.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market share or higher procedure volumes for knee replacement surgeries, while a decrease may signal competitive pressure or market saturation.
Detailed definition
This metric represents the total net revenue generated from the sale of knee replacement medical devices and related ort...
Peer comparison
Comparable to orthopedic reconstruction revenue segments reported by competitors like Stryker, Zimmer Biomet, and Smith & Nephew.
jnj_segment_knees_sales_to_customers_note_9Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $634.00M | $700.00M | $631.00M | $737.00M | $678.00M | $698.00M | $635.00M | $736.00M | $676.00M | $803.00M | $787.00M | $704.00M | $796.00M | $778.00M | $779.00M | $753.00M |
| QoQ Change | — | +10.4% | -9.9% | +16.8% | -8.0% | +2.9% | -9.0% | +15.9% | -8.2% | +18.8% | -2.0% | -10.5% | +13.1% | -2.3% | +0.1% | -3.3% |
| YoY Change | — | — | — | — | +6.9% | -0.3% | +0.6% | +8.6% | -3.2% | — | +6.9% | +4.1% | — | -3.1% | -1.0% | +7.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's knees — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported knees — sales to customers (note 9) of $753.00M in Q3 2025.
- How has Johnson & Johnson's knees — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's knees — sales to customers (note 9) increased by 7.0% year-over-year, from $704.00M to $753.00M.
- What is the long-term trend for Johnson & Johnson's knees — sales to customers (note 9)?
- Over 2 years (2021 to 2024), Johnson & Johnson's knees — sales to customers (note 9) has grown at a 14.9% compound annual growth rate (CAGR), from $2.34B to $3.09B.
- What does knees — sales to customers (note 9) mean?
- The total revenue earned from selling knee replacement products.